NCT00962338

Brief Summary

The investigators want to identify limiting factors for short convalescence after laparoscopic groin hernia repair. Before the operation patients are given intensive structured information about one day´s convalescence. Patients fill out questionnaire before operation about several clinically relevant parameters. This is also done first 3 days after operation and after 1 month and 6 months. The patients are seen for clinical control at 1 and 6 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
210

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2009

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

August 19, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 20, 2009

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2010

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

August 26, 2024

Status Verified

August 1, 2024

Enrollment Period

1.3 years

First QC Date

August 19, 2009

Last Update Submit

August 22, 2024

Conditions

Keywords

convalescencepainnauseavomitingsexual dysfunction

Outcome Measures

Primary Outcomes (1)

  • duration of convalescence

    3 weeks in average

Secondary Outcomes (9)

  • Pain scores on visual analog scale and verbal rating scale

    6 months

  • fatigue scores on numeric rating scale (1-10)

    6 months

  • sexual dysfunction

    6 months

  • nausea scores on verbal rating scale

    3 days

  • vomiting

    3 days

  • +4 more secondary outcomes

Study Arms (1)

lap. inguinal herniorrhaphy

Patients undergoing planned lap. inguinal herniorrhaphy

Behavioral: Information

Interventions

InformationBEHAVIORAL

Information on short convalescence (1 day). Example: Operated today and getting started with normal activities again tomorrow.

Also known as: Groin hernia repair, TAPP, Convalescence
lap. inguinal herniorrhaphy

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The population are from Region Sjaelland and are planned for laparoscopic inguinal or femoral herniorrhaphy. Single university hospital department i Denmark.

You may qualify if:

  • planned laparoscopic inguinal or femoral herniorrhaphy
  • ASA class I-II
  • speak and read danish

You may not qualify if:

  • converting to open operation
  • low compliance (dementia, psychiatric disorder)
  • use of morphine or similar drugs daily in the last month
  • complications to the operation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Køge

Koege, Region Sjælland, 4600, Denmark

Location

Related Publications (2)

  • Tolver MA, Rosenberg J. Pain during sexual activity before and after laparoscopic inguinal hernia repair. Surg Endosc. 2015 Dec;29(12):3722-5. doi: 10.1007/s00464-015-4143-8. Epub 2015 Mar 18.

  • Tolver MA, Strandfelt P, Rosenberg J, Bisgaard T. Female gender is a risk factor for pain, discomfort, and fatigue after laparoscopic groin hernia repair. Hernia. 2013 Jun;17(3):321-7. doi: 10.1007/s10029-012-0956-8. Epub 2012 Jul 12.

MeSH Terms

Conditions

Hernia, InguinalConvalescencePainNauseaVomitingSexual Dysfunction, Physiological

Interventions

tetra-4-amidinophenoxypropane

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsDisease AttributesPathologic ProcessesNeurologic ManifestationsSigns and SymptomsSigns and Symptoms, DigestiveGenital DiseasesUrogenital Diseases

Study Officials

  • Mette A Tolver, M.D.

    University Hospital Køge

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

August 19, 2009

First Posted

August 20, 2009

Study Start

August 1, 2009

Primary Completion

December 1, 2010

Study Completion

June 1, 2011

Last Updated

August 26, 2024

Record last verified: 2024-08

Locations